Carole Guillonneau
Carole Guillonneau
Verified email at
Cited by
Cited by
CD40Ig treatment results in allograft acceptance mediated by CD8+CD45RClow T cells, IFN-γ, and indoleamine 2,3-dioxygenase
C Guillonneau, M Hill, FX Hubert, E Chiffoleau, C Hervé, XL Li, M Heslan, ...
The Journal of clinical investigation 117 (4), 1096-1106, 2007
Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunity
C Guillonneau, JD Mintern, FX Hubert, AC Hurt, GS Besra, S Porcelli, ...
Proceedings of the National Academy of Sciences 106 (9), 3330-3335, 2009
Donor-specific allograft tolerance by administration of recipient-derived immature dendritic cells and suboptimal immunosuppression
G Bériou, H Pêche, C Guillonneau, E Merieau, MC Cuturi
Transplantation 79 (8), 969-972, 2005
Mechanism and localization of CD8 regulatory T cells in a heart transplant model of tolerance
XL Li, S Ménoret, S Bezie, L Caron, D Chabannes, M Hill, F Halary, ...
The Journal of Immunology 185 (2), 823-833, 2010
Prolonged blockade of CD40-CD40 ligand interactions by gene transfer of CD40Ig results in long-term heart allograft survival and donor-specific hyporesponsiveness, but does not …
C Guillot, C Guillonneau, P Mathieu, CA Gerdes, S Ménoret, C Braudeau, ...
The Journal of Immunology 168 (4), 1600-1609, 2002
IL-34 is a Treg-specific cytokine and mediates transplant tolerance
S Bézie, E Picarda, J Ossart, L Tesson, C Usal, K Renaudin, I Anegon, ...
The Journal of clinical investigation 125 (10), 3952-3964, 2015
Fms-like tyrosine kinase 3 ligand recruits plasmacytoid dendritic cells to the brain
JF Curtin, GD King, C Barcia, C Liu, FX Hubert, C Guillonneau, R Josien, ...
The Journal of Immunology 176 (6), 3566-3577, 2006
Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade
C Guillonneau, V Aubry, K Renaudin, C Séveno, C Usal, K Tezuka, ...
Transplantation 80 (4), 546-554, 2005
Constraints within major histocompatibility complex class I restricted peptides: presentation and consequences for T-cell recognition
A Theodossis, C Guillonneau, A Welland, LK Ely, CS Clements, ...
Proceedings of the National Academy of Sciences 107 (12), 5534-5539, 2010
Immunoregulatory properties of the cytokine IL-34
C Guillonneau, S Bézie, I Anegon
Cellular and Molecular Life Sciences 74 (14), 2569-2586, 2017
Protective Efficacy of Cross-Reactive CD8+ T Cells Recognising Mutant Viral Epitopes Depends on Peptide-MHC-I Structural Interactions and T Cell Activation …
SA Valkenburg, S Gras, C Guillonneau, NL La Gruta, PG Thomas, ...
PLoS pathogens 6 (8), e1001039, 2010
Active suppression of allogeneic proliferative responses by dendritic cells after induction of long-term allograft survival by CTLA4Ig
C Guillot, S Ménoret, C Guillonneau, C Braudeau, MG Castro, ...
Blood, The Journal of the American Society of Hematology 101 (8), 3325-3333, 2003
Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses
AE Denton, R Wesselingh, S Gras, C Guillonneau, MR Olson, JD Mintern, ...
The Journal of Immunology 187 (11), 5733-5744, 2011
Killer T cells in influenza
J Stambas, C Guillonneau, K Kedzierska, JD Mintern, PC Doherty, ...
Pharmacology & therapeutics 120 (2), 186-196, 2008
Structural basis for enabling T-cell receptor diversity within biased virus-specific CD8+ T-cell responses
EB Day, C Guillonneau, S Gras, NL La Gruta, DAA Vignali, PC Doherty, ...
Proceedings of the National Academy of Sciences 108 (23), 9536-9541, 2011
Identification of a new member of the CD20/FcεRIβ family overexpressed in tolerated allografts
C Louvet, E Chiffoleau, M Heslan, L Tesson, JM Heslan, R Brion, ...
American journal of transplantation 5 (9), 2143-2153, 2005
Cutting edge: tissue-resident memory CTL down-regulate cytolytic molecule expression following virus clearance
JD Mintern, C Guillonneau, FR Carbone, PC Doherty, SJ Turner
The Journal of Immunology 179 (11), 7220-7224, 2007
CD8+ regulatory T cells in solid organ transplantation
C Guillonneau, E Picarda, I Anegon
Current opinion in organ transplantation 15 (6), 751-756, 2010
Ex vivo expanded human non-cytotoxic CD8+ CD45RClow/− Tregs efficiently delay skin graft rejection and GVHD in humanized mice
S Bézie, D Meistermann, L Boucault, S Kilens, J Zoppi, E Autrusseau, ...
Frontiers in immunology 8, 2014, 2018
MHC-derived allopeptide activates TCR-biased CD8+ Tregs and suppresses organ rejection
E Picarda, S Bézie, V Venturi, K Echasserieau, E Mérieau, A Delhumeau, ...
The Journal of clinical investigation 124 (6), 2497-2512, 2014
The system can't perform the operation now. Try again later.
Articles 1–20